ADCT
ADC Therapeutics SA
$1.28
-0.07 (-5.19%)
At close · Jul 8
Market Cap
$162.80M
Shares
127,191,158
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-02 | 2026-06-30 | |
| 8-K | 2026-06-24 | — | |
| 8-K | 2026-06-03 | — | |
| 8-K | 2026-06-02 | 2026-06-01 | |
| 10-Q | 2026-05-04 | 2026-03-31 | |
| 8-K | 2026-05-04 | — | |
| DEF 14A | 2026-04-20 | 2026-06-01 | |
| 8-K | 2026-03-10 | — | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-02-23 | 2026-02-18 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-12-05 | 2025-12-03 | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-10-14 | 2025-10-12 | |
| 8-K | 2025-09-30 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-12 | 2025-06-11 | |
| 8-K | 2025-06-05 | 2025-06-03 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| DEF 14A | 2025-04-21 | 2025-06-03 | |
| 8-K | 2025-03-27 | — | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-13 | 2024-11-11 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| DEF 14A | 2024-09-23 | 2024-11-11 | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 8-K | 2024-05-14 | — | |
| 8-K | 2024-05-08 | 2024-05-06 | |
| 10-Q | 2024-05-06 | 2024-03-31 | |
| 8-K | 2024-05-06 | — | |
| DEF 14A | 2024-04-26 | 2024-06-13 | |
| 8-K | 2024-04-09 | — | |
| 10-K | 2024-03-13 | 2023-12-31 | |
| 8-K | 2024-03-13 | — | |
| 8-K | 2024-03-05 | — | |
| 8-K | 2024-02-29 | 2024-02-23 | |
| 8-K | 2024-01-24 | 2024-01-18 | |
| 8-K | 2024-01-19 | 2024-01-16 | |
| 8-K | 2024-01-04 | — | |
| 8-K | 2024-01-04 | — | |
| 6-K | 2023-12-19 | — | |
| 6-K | 2023-11-07 | 2023-09-30 |
Showing 1–50 of 177 filings